pa9159
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 10, 2021 (NCT05170763)
Timeline
Indications
Studied for
Mechanism of action
- Prostanoid DP receptorANTAGONIST
PTGDR antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06916273 | Phase 1 | Jul 22, 2024 | Anhui Kedgene Biotechnology Co.,Ltd, Nanchang University |
| NCT05234580 | Phase 2 | Apr 15, 2022 | Anhui Kedgene Biotechnology Co.,Ltd, Capital Medical University |
| NCT05170763 | Phase 1 | Nov 10, 2021 | Anhui Kedgene Biotechnology Co.,Ltd, Capital Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Kedgene Biotechnology Co.,Ltd | For profit | 3 | 3 | 2 | 2021 |
| Capital Medical University | Academic/Hospital | 2 | 0 | 2 | 2021 |
| Nanchang University | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1